The International Collaboration for Transfusion Medicine Guidelines’ (ICTMG) Use of Intravenous Albumin guideline: Moving evidence into practice

Join the third Breakthroughs in blood: Advancements into action 1.5 hour webinar as Dr. Sheharyar Raza discusses Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines published in the peer reviewed journal CHEST in March 2024.   

Albumin is used across a wide range of clinical settings to improve hemodynamics, to facilitate fluid removal, and to manage complications of cirrhosis; however, few evidence-based indications support the routine use of albumin in clinical practice to improve patient outcomes. This guideline provides actionable recommendations for health-care professionals on the use of albumin in common clinical settings.    

We invite you to take part in a round table panel discussion during the webinar to understand more about the impact of this study on your current practice.

Presented by: 

Sheharyar Raza, MD, MSc, FRCPC
Transfusion Medicine – Toronto, Canada 

Moderated by:  

Jeannie Callum, MD, FRCPC 
Transfusion Medicine - Kingston, Canada 

Panelists: 

Ted Clark, MD, MSc, FRCPC 
Nephrology – Ottawa, Canada 

Bram Rochwerg, MD, MSc, FRCPC
Critical care – Hamilton, Canada

Alexander Vlaar, MD, PhD, MBA
Intensive Care Medicine – Amsterdam, The Netherlands

James Daly, MBBS, FRACP, FRCPA
Hematology - Brisbane, Australia

Simon Stanworth, FRCP FRC
Transfusion Medicine/Haematology - Oxford, UK

Learning Objectives: 

1. Review albumin physiology and the albumin products available. 
2. Discuss risks of albumin transfusions. 
3. Review methodology used by ICTMG’s guideline development group for this guideline.  
4. Discuss the evidence and recommendations for appropriate albumin use in settings where it is commonly prescribed (cirrhosis, critical care, kidney failure, cardiovascular surgery). 
5. Learn from the panel experts about how they are working to improve the evidence-base for albumin and their efforts to de-prescribe albumin at their organizations. 

Prior to attending this webinar, it is recommended to read the guideline: Intravenous albumin and the systematic review of the evidence for patients undergoing cardiovascular surgery: Intravenous albumin in cardiac and vascular surgery: a systematic review and meta-analysis.

Registration: 

Register for the Zoom meeting here.  

Downloadable event poster available below: 

Breakthroughs in blood: Advancements into action  

The Breakthroughs in blood: Advancements into action webinar series is curated for health-care professionals, hospital administrators, policy-makers, and researchers who want to stay at the forefront of groundbreaking blood research and adopt cutting-edge best practices. Hosted by the esteemed Dr. Jeannie Callum and coordinated by Canadian Blood Services, this series delves deep into the "So what?" and "Now what?" of blood science and medical research, with a dedicated focus on transfusion clinical trials and guidelines. Don't miss this unique opportunity to advance your knowledge and take actionable steps toward a better healthcare future.  

Resources 

The Breakthroughs in blood: Advancements into action recording, dissemination and implementation resources are made available at Breakthroughs in blood: Advancing practice through research | Professional Education. 

For additional resources that have been developed to support knowledge mobilization of this guideline, visit the ICTMG.org website. Guideline endorsements are also being noted on this page as they are received.